Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 21Colonic Neoplasms 13Rectal Neoplasms 12Neoplasm Metastasis 11Cholangiocarcinoma 9Stomach Neoplasms 8Liver Neoplasms 3Esophageal Neoplasms 3Carcinoma, Hepatocellular 2Adenocarcinoma Of Esophagus 2Resected Liver Metastases From Colorectal Cancer 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neoplasms 1Nasopharyngeal Carcinoma 1Gastrointestinal Stromal Tumors 1Colorectal Adenocarcinoma Metastatic to the Liver 1Cirrhosis, Familial, with Pulmonary Hypertension 1Carcinoma, Pancreatic Ductal 1Carcinoma, Ovarian Epithelial 1Appendiceal Neoplasms 1

Interventions

Gemcitabine 406Oxaliplatin 131Fluorouracil 125130-nm albumin-bound paclitaxel 108Capecitabine 100Albumin-Bound Paclitaxel 90Leucovorin 88Irinotecan 87Radiotherapy 76Radiosurgery 64Taxes 63Cisplatin 56Erlotinib Hydrochloride 44Drug Therapy 42folfirinox 40Magnetic Resonance Spectroscopy 39pembrolizumab 35Blood Specimen Collection 33S 1 (combination) 31Pancreaticoduodenectomy 31Docetaxel 31Nivolumab 30Bevacizumab 30Biopsy 26Surgical Procedures, Operative 25Cyclophosphamide 25irinotecan sucrosofate 24Specimen Handling 24Radiation 22Standard of Care 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Pancreatic Neoplasms × Floxuridine × Clear all
NCT03856658 2025-06-17

Hepatic Artery Infusional Floxuridine to Treat Pancreatic Cancer Liver Metastases

Corewell Health West

Phase 2 Active not recruiting
14 enrolled
Gastrointestinal

Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡